nope , sold out el== around 40 and the rest at 18 when crl came out. crap stock , generics with lame revenue , om=r now , great billion dollar pipeline with multi ph3 trials with no approved therapy yet. not much action here , some said ir=c was a better play than ldsr , but it dropped 60% in 2 days time , bought a mil here for 2k , realy cheap , we'll see how it plays out